GGrantIndex
← Search

Cancer Research Career Enhancement and Related Activities

$347,968P30FY2022CANIH

Fred Hutchinson Cancer Center, Seattle WA

Investigators

Linked publications, trials & patents

Trial NCT06995898Trial NCT06682039Trial NCT06484595Trial NCT06193070Trial NCT05947500Trial NCT05930496Trial NCT05183828Trial NCT04902144Trial NCT04751383Trial NCT04682301Trial NCT04667481Trial NCT04660331Trial NCT04539366Trial NCT04505553Trial NCT04502524Trial NCT04500548Trial NCT04496219Trial NCT04489719Trial NCT04472338Trial NCT04466475Trial NCT04447313Trial NCT04444232Trial NCT04442581Trial NCT04431479Trial NCT04410900Trial NCT04387227Trial NCT04384692Trial NCT04383743Trial NCT04375631Trial NCT04372927Trial NCT04370301Trial NCT04359784Trial NCT04336943Trial NCT04329065Trial NCT04282187Trial NCT04260776Trial NCT04257578Trial NCT04254133Trial NCT04231877Trial NCT04220229Trial NCT04211766Trial NCT04208724Trial NCT04205409Trial NCT04200482Trial NCT04198922Trial NCT04196010Trial NCT04195945Trial NCT04195633Trial NCT04194918Trial NCT04188912Trial NCT04175431Trial NCT04156828Trial NCT04155840Trial NCT04151940Trial NCT04120246Trial NCT04111497Trial NCT04083183Trial NCT04083170Trial NCT04081779Trial NCT04081298Trial NCT04062955Trial NCT04060849Trial NCT03999515Trial NCT03991884Trial NCT03986502Trial NCT03980769Trial NCT03970096Trial NCT03907527Trial NCT03891784Trial NCT03864419Trial NCT03807063Trial NCT03806192Trial NCT03781778Trial NCT03779867Trial NCT03779854Trial NCT03778021Trial NCT03776864Trial NCT03749460Trial NCT03747484Trial NCT03737955Trial NCT03723863Trial NCT03718338Trial NCT03672981Trial NCT03670966Trial NCT03670069Trial NCT03660930Trial NCT03649841Trial NCT03641287Trial NCT03606486Trial NCT03602898Trial NCT03600038Trial NCT03585231Trial NCT03574012Trial NCT03570476Trial NCT03531918Trial NCT03525106Trial NCT03523195Trial NCT03522584Trial NCT03518242Trial NCT03516812

Abstract

PROJECT SUMMARY: CANCER RESEARCH CAREER ENHANCEMENT (CRCE) The Fred Hutch/University of Washington Cancer Consortium aims to be at the forefront of training the next generation of scientists and clinicians to best position them to lead efforts to eliminate cancer. Education and training has always been a core value and central to our mission, and we propose here to continue to emphasize and enhance our training mission and footprint. The specific aims for CRCE are (1) to provide exceptional training and support for graduate students and postdoctoral and clinical fellows so that they will be poised to tackle a range of careers in cancer research; (2) to encourage young students to engage in and experience science and to provide exposure and opportunities for those from groups that are underrepresented minorities (URMs) in science; (3) to maximize the success of junior faculty through mentoring and support as they transition to independent scientists; and (4) to support the pipeline of educational and training opportunities of the Consortium. To support our training efforts, we host a large and comprehensive set of T32 grants (n=47), of which 32 have Consortium faculty as mentors, 17 are led by Consortium PIs, and 7 are from NCI. The eight T32s with the strongest cancer focus collectively support 39 trainees/year, and an additional 95 trainees are supported by T32s that include cancer research as a component. Some of these grants have been in continuous existence for more than 4 decades (e.g., Molecular & Cellular Biology, Medical Scientist Training Program, Medical Genetics, Hematology). The caliber of our trainees and their success is illustrated by current active awards of 1 K99 grant, 6 K01 or K22 grants, 10 F32 grants, 2 Jane Coffin Childs Fellowships, 4 Damon Runyon Cancer Research Awards, and 4 Susan G. Komen Fellowships. This Cancer Research Career Enhancement (CRCE) component will serve as a centralized resource that integrates and supports these efforts, encourages the continuum of training and mentoring, and supports continued innovation in our education pipeline.

View original record on NIH RePORTER →